SCOTTSDALE, Ariz., Nov. 30, 2009 (GLOBE NEWSWIRE) -- Health Enhancement Products, Inc. (OTCBB:HEPI - News) announced today that Interim CEO, Peter Vitulli, will be presenting at the 2nd annual LD MICRO Conference on Thursday, December 3, 2009 at 4:00 P.M. PST. The conference is taking place at the Luxe Sunset Bel Air Hotel in Los Angeles, CA.

Peter Vitulli, Interim CEO, commented, "We are excited to be able to continue our proactive Investor Relations efforts by presenting the HEPI story to small and micro cap investors at the 2nd annual LD MICRO Conference. This venue is a great opportunity for us to introduce our story and what we believe to be exciting break-through science to a targeted audience."

About Health Enhancement Products, Inc.

Health Enhancement Products, Inc. (OTCBB:HEPI - News) is a health & wellness company engaged in the development of a product comprised of pure, all-natural compounds that can be used as a dietary supplement and food additive. The Company's product is ProAlgaZyme(R)(PAZ(TM)), a liquid product drawn from living algae grown in purified water. The water in which the algae are grown is drawn off, filtered and bottled under the trademark ProAlgaZyme(R).

Safe Harbor Statement

Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the timing of completion of a trial, actual future clinical trial results being different than the results the company has obtained to date, and the company's ability to secure funding. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and those actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.

For more information, please visit http://www.heponline.com.

American Capital Ventures, Inc.
IR Contact:
Howard Gostfrand
David Sasso
305.918.7000
info@amcapventures.com
www.amcapventures.com